Opiant Pharmaceuticals Inc

NASDAQ:OPNT   1:30:07 PM EDT
8.34
+0.13 (+1.58%)
Earnings Announcements

Opiant Pharmaceuticals Reports Q3 2020 Financial Results

Published: 11/12/2020 21:38 GMT
Opiant Pharmaceuticals Inc (OPNT) - Opiant Pharmaceuticals Announces Third Quarter 2020 Financial Results and Corporate Update.
Q3 Earnings per Share $0.15.
Q3 Earnings per Share Estimate $-0.21 -- Refinitiv Ibes Data (analyst estimates).
Now Expect a Cash Balance at End of 2020 of Approximately $30 Million.
Revenue is expected to be $9.2 Million
Adjusted EPS is expected to be $0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.